Brett A. Pletcher

2019

In 2019, Brett A. Pletcher earned a total compensation of $5M as Executive Vice President, Corporate Affairs and General Counsel at Gilead Sciences.

Compensation breakdown

Non-Equity Incentive Plan$1,235,000
Option Awards$749,946
Salary$891,000
Stock Awards$2,144,734
Other$12,000
Total$5,032,680

Pletcher received $2.1M in stock awards, accounting for 43% of the total pay in 2019.

Pletcher also received $1.2M in non-equity incentive plan, $749.9K in option awards, $891K in salary and $12K in other compensation.

Rankings

In 2019, Brett A. Pletcher's compensation ranked 2,183rd out of 13,971 executives tracked by ExecPay. In other words, Pletcher earned more than 84.4% of executives.

ClassificationRankingPercentile
All
2,183
out of 13,971
84th
Division
Manufacturing
793
out of 5,692
86th
Major group
Chemicals And Allied Products
249
out of 2,189
89th
Industry group
Drugs
201
out of 1,875
89th
Industry
Biological Products, Except Diagnostic Substances
50
out of 389
87th

Pay ratio

Brett A. Pletcher's Pay$5,032,680
Median Employee's Pay$173,264
Pay Ratio

29

to 1

In 2019, the annual total compensation of Brett A. Pletcher was $5,032,680.

The annual total compensation of the median employee at Gilead Sciences was $173,264.

The ratio of Brett A. Pletcher's pay to the pay of median employee was therefore 29 to one.

Source: SEC filing on March 24, 2020.

Pletcher's colleagues

We found eight more compensation records of executives who worked with Brett A. Pletcher at Gilead Sciences in 2019.

2019

Daniel O'Day

Gilead Sciences

Chief Executive Officer

2019

Johanna Mercier

Gilead Sciences

Chief Commercial Officer

2019

Gregg Alton

Gilead Sciences

Chief Executive Officer

2019

Laura Hamill

Gilead Sciences

Former Executive Vice President Worldwide Commercial Operations

2019

Robin Washington

Gilead Sciences

Chief Financial Officer

2019

Andrew Dickinson

Gilead Sciences

Chief Financial Officer

2019

John McHutchison

Gilead Sciences

Chief Scientific Officer

2019

Merdad Parsey

Gilead Sciences

Chief Medical Officer

News

You may also like